Cite Filings / ORKA / 0001193125-24-085440
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
425

Prospectus/Communication re Business Combination

Oruka Therapeutics, Inc. · Filed 2024-04-03 · Acc 0001193125-24-085440

Documents 1

  • 425 Prospectus/Communication re Business Combination , d794675d425.htm

Around this filing

  • 2024-04-25 425 Prospectus/Communication re Business Combination
  • 2024-04-05 SC 13G/A Amended Statement of Ownership
  • 2024-04-05 SC 13D Beneficial Ownership Report
  • 2024-04-04 8-K Executive or director change
  • 2024-04-03 425 Prospectus/Communication re Business Combination
  • 2024-04-03 8-K Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  • 2009-01-27 425 Prospectus/Communication re Business Combination

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d794675d425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…